Mohammad Alashqar: A Year in Thrombosis – What Changed?
Mohammad Alashqar, Postdoctoral Pharmacotherapy Research Fellow at The Ohio State University College of Pharmacy, shared on LinkedIn:
“World Thrombosis Day 2026 | A Year in Thrombosis: What Changed?
On World Thrombosis Day, I wanted to look beyond awareness and reflect on how the thrombosis field has evolved over the past year – October 13, 2025 to October 13, 2026.
It has been an important year for thrombosis research and clinical practice, with evolving guidelines, new therapeutic developments, major Phase 3 trial results, regulatory updates, and continued progress toward safer antithrombotic strategies.
The year also reinforced an important lesson: progress is not defined only by positive trials. Negative and neutral studies are equally valuable when they refine our understanding of where, when, and in whom new therapies should be used.
One of the most closely watched areas remains Factor XI/XIa inhibition, where agents such as asundexian, milvexian, and abelacimab continue to test a compelling question:
Can we prevent thrombosis effectively while causing less bleeding?
The answer will require rigorous evidence, appropriate patient selection, and careful interpretation of both successes and setbacks.
This infographic highlights selected developments from the past 12 months and the directions that may shape the next chapter of thrombosis prevention and treatment.
On World Thrombosis Day, the mission remains clear:
Prevent clots. Optimize care. Advance science. Improve lives.”
Stay updated with Hemostasis Today.
-
Oct 14, 2026, 13:43Felicity Appiah: Understanding the Bethesda System for Cervical Cytology
-
Oct 14, 2026, 13:32Bernard-Soulier syndrome in the Genomic Era: From GP Ib-IX-V Dysfunction to Precision Diagnosis
-
Oct 14, 2026, 11:58Cesare Medri: A New Learning Achievement in Haemoglobin Disorder Care
-
Oct 14, 2026, 07:36Daniel Pereira Monteiro: ASCAT 2026 A Day of Science, Connection and Community
-
Oct 14, 2026, 07:20Rachael Jackman: Understanding Models of Transfusion Medicine at AABB 2026
-
Oct 14, 2026, 07:09Dianne E. van der Wal: New Academic Chapter in Platelet Science and Biomedical Education
-
Oct 14, 2026, 06:55Mahdieh Dagina Pedersen: A Meaningful Milestone in Hemophilia A Research and Oral Drug Development
-
Oct 14, 2026, 06:37Neoklis Mparis: Unilateral Adrenal Haemorrhage in Primary Antiphospholipid Syndrome During Bridging Anticoagulation
-
Oct 14, 2026, 06:00Aymen A.: LAAC vs. OAC in Patients with Atrial Fibrillation Including CHAMPION-AF and CLOSURE-AF Trials